| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.53 | 0.0001 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.29 | 0.0001 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.094 | 0.0005 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.0009 |